<drug type="small molecule" created="2015-11-30" updated="2017-03-21">
  <drugbank-id primary="true">DB09552</drugbank-id>
  <name>Thonzonium bromide</name>
  <description>Thonzonium Bromide is a cationic surface-active compound. As an additive to pharmacologic formulations, thonzonium bromide causes dispersion and penetration of cellular debris and exudate, thereby promoting tissue contact of the administered medication.</description>
  <cas-number/>
  <unii>JI2B19CR0R</unii>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links>
      <link>
        <title>Pubchem</title>
        <url>https://pubchem.ncbi.nlm.nih.gov/compound/11102#section=Drug-Labels-for-Ingredients</url>
      </link>
      <link>
        <title>Wikipedia</title>
        <url>https://en.wikipedia.org/wiki/Thonzonium_bromide</url>
      </link>
    </links>
  </general-references>
  <synthesis-reference/>
  <indication>It is used in cortisporin-TC ear drops to help penetration of active ingredients through cellular debris for its antibacterial action.</indication>
  <pharmacodynamics>Thonzonium bromide causes dispersion and penetration of cellular debris and exudate, thereby promoting tissue contact of the administered medication.</pharmacodynamics>
  <mechanism-of-action/>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <salts/>
  <synonyms/>
  <products>
    <product>
      <name>Coly-mycin S</name>
      <labeller>Par Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>42023-108</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Coly-mycin S</name>
      <labeller>Endo Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>63481-421</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-04-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cortisporin-TC</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-0564</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-05-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Cortisporin-TC</name>
      <labeller>Par Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>42023-109</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Suspension</dosage-form>
      <strength/>
      <route>Auricular (otic)</route>
      <fda-application-number>NDA050356</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Cortisporin-TC</name>
      <ingredients>Colistin + Neomycin + Thonzonium bromide + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Cortisporin-TC</name>
      <ingredients>Colistin + Neomycin + Thonzonium bromide + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Coly-mycin S</name>
      <ingredients>Colistin + Neomycin + Thonzonium bromide + Hydrocortisone</ingredients>
    </mixture>
    <mixture>
      <name>Coly-mycin S</name>
      <ingredients>Colistin + Neomycin + Thonzonium bromide + Hydrocortisone</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Amines</category>
      <mesh-id>D000588</mesh-id>
    </category>
    <category>
      <category>Ammonium Compounds</category>
      <mesh-id>D064751</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds</category>
      <mesh-id>D006571</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds, 1-Ring</category>
      <mesh-id>D006573</mesh-id>
    </category>
    <category>
      <category>Inorganic Chemicals</category>
      <mesh-id>D007287</mesh-id>
    </category>
    <category>
      <category>Nitrogen Compounds</category>
      <mesh-id>D017672</mesh-id>
    </category>
    <category>
      <category>Onium Compounds</category>
      <mesh-id>D009861</mesh-id>
    </category>
    <category>
      <category>Organic Chemicals</category>
      <mesh-id>D009930</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Suspension</form>
      <route>Auricular (otic)</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties/>
  <experimental-properties/>
  <external-identifiers/>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>
